Jason Hope is an entrepreneur, investor who has invested his cash in SENS foundation. SENS foundation was established in 2009. The aim and the goals of this foundation are fights age-related diseases. In the year 2010, Jason donated of $ 500,000 to SENS foundation. This has helped the foundation to build a highly specialized laboratory to carry out new research.Therefore they can research with no difficulty. Jason`s dreams in some years to come are to see doctors able to cure deadly diseases that had no cure. Some of these diseases are heart diseases, cancer, and Parkinson`s disease.
Jason is much concerned with the welfare of many especially in term of health. He explains that advancement of medical technology is significant because it will help doctors treat their patient with ease. This is because technology has simplified everything through research of those deadly diseases and ways to manage them. SENS foundation has helped in the contribution of advancement of medical technology and research.SENS Foundation is searching for ways to deals with damages that occur from time to time before the diseases develop fully in the body. SENS is also finding the cure for diseases that affect all functioning of the body that makes us age faster than we should. SENS is much determined on stopping and preventing those disease forever.
Jason was born and brought up in a temple located in Arizona. He received his MBA from Arizona state of the university. After Jason was through with his college he engaged himself with some business he merged successful, and he was all known over the world within a short time. Many people consult Jason about how to be successful and all those who need business advice. This is because he is a well-known expert and advisor on business question international. Jason Hope supports SENS not only financially but helps this foundation to connect with another source. SENS means Strategies for Engineered Negligible Senescence. It is a non- profit organization that support scientists, philanthropists and researchers.